<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2020-10-07" version="197">
<accession>P21730</accession>
<name>C5AR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>C5a anaphylatoxin chemotactic receptor 1</fullName>
</recommendedName>
<alternativeName>
<fullName>C5a anaphylatoxin chemotactic receptor</fullName>
<shortName>C5a-R</shortName>
<shortName>C5aR</shortName>
</alternativeName>
<cdAntigenName>CD88</cdAntigenName>
</protein>
<gene>
<name type="primary">C5AR1</name>
<name type="synonym">C5AR</name>
<name type="synonym">C5R1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="2993" last="2999">
<title>Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.</title>
<authorList>
<person name="Boulay F."/>
<person name="Mery L."/>
<person name="Tardif M."/>
<person name="Brouchon L."/>
<person name="Vignais P."/>
</authorList>
<dbReference type="PubMed" id="2007135"/>
<dbReference type="DOI" id="10.1021/bi00226a002"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS ASN-2 AND ASN-279</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Nature" volume="349" first="614" last="617">
<title>The chemotactic receptor for human C5a anaphylatoxin.</title>
<authorList>
<person name="Gerard N.P."/>
<person name="Gerard C."/>
</authorList>
<dbReference type="PubMed" id="1847994"/>
<dbReference type="DOI" id="10.1038/349614a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
<scope>VARIANTS ASN-2 AND ASN-279</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Kopatz S.A."/>
<person name="Aronstam R.S."/>
<person name="Sharma S.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ASN-2 AND ASN-279</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ASN-2 AND ASN-279</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS ASN-2 AND ASN-279</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Biochemistry" volume="32" first="1243" last="1250">
<title>Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene.</title>
<authorList>
<person name="Gerard N.P."/>
<person name="Bao L."/>
<person name="Xiao-Ping H."/>
<person name="Eddy R.L. Jr."/>
<person name="Shows T.B."/>
<person name="Gerard C."/>
</authorList>
<dbReference type="PubMed" id="8383526"/>
<dbReference type="DOI" id="10.1021/bi00056a007"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-3</scope>
<scope>VARIANT ASN-2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="14446" last="14450">
<title>The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.</title>
<authorList>
<person name="DeMartino J.A."/>
<person name="Van Riper G."/>
<person name="Siciliano S.J."/>
<person name="Molineaux C.J."/>
<person name="Konteatis Z.D."/>
<person name="Rosen H."/>
<person name="Springer M.S."/>
</authorList>
<dbReference type="PubMed" id="8182049"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 2-ASP--LEU-22; 2-ASP--SER-30; ASP-10; ASP-15; ASP-16; ASP-18 AND ASP-21</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="16625" last="16629">
<title>Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.</title>
<authorList>
<person name="Monk P.N."/>
<person name="Barker M.D."/>
<person name="Partridge L.J."/>
<person name="Pease J.E."/>
</authorList>
<dbReference type="PubMed" id="7622471"/>
<dbReference type="DOI" id="10.1074/jbc.270.28.16625"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF GLU-199</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="19166" last="19172">
<title>Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo.</title>
<authorList>
<person name="Giannini E."/>
<person name="Brouchon L."/>
<person name="Boulay F."/>
</authorList>
<dbReference type="PubMed" id="7642584"/>
<dbReference type="DOI" id="10.1074/jbc.270.32.19166"/>
</citation>
<scope>PHOSPHORYLATION AT SER-314; SER-317; SER-327; SER-332; SER-334 AND SER-338</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="10411" last="10419">
<title>Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.</title>
<authorList>
<person name="Chen Z."/>
<person name="Zhang X."/>
<person name="Gonnella N.C."/>
<person name="Pellas T.C."/>
<person name="Boyar W.C."/>
<person name="Ni F."/>
</authorList>
<dbReference type="PubMed" id="9553099"/>
<dbReference type="DOI" id="10.1074/jbc.273.17.10411"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR C5A</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="1656" last="1664">
<title>Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.</title>
<authorList>
<person name="Christophe T."/>
<person name="Rabiet M.J."/>
<person name="Tardif M."/>
<person name="Milcent M.D."/>
<person name="Boulay F."/>
</authorList>
<dbReference type="PubMed" id="10636859"/>
<dbReference type="DOI" id="10.1074/jbc.275.3.1656"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-314; SER-317; SER-327; SER-332; SER-334 AND SER-338</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="J. Exp. Med." volume="193" first="1059" last="1066">
<title>Sulfated tyrosines contribute to the formation of the c5a docking site of the human c5a anaphylatoxin receptor.</title>
<authorList>
<person name="Farzan M."/>
<person name="Schnitzler C.E."/>
<person name="Vasilieva N."/>
<person name="Leung D."/>
<person name="Kuhn J."/>
<person name="Gerard C."/>
<person name="Gerard N.P."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="11342590"/>
<dbReference type="DOI" id="10.1084/jem.193.9.1059"/>
</citation>
<scope>SULFATION AT TYR-11 AND TYR-14</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4277" last="4285">
<title>Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.</title>
<authorList>
<person name="Braun L."/>
<person name="Christophe T."/>
<person name="Boulay F."/>
</authorList>
<dbReference type="PubMed" id="12464600"/>
<dbReference type="DOI" id="10.1074/jbc.m210120200"/>
</citation>
<scope>INTERACTION WITH ARRB1 AND ARRB2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="35345" last="35353">
<title>C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor.</title>
<authorList>
<person name="Klco J.M."/>
<person name="Lassere T.B."/>
<person name="Baranski T.J."/>
</authorList>
<dbReference type="PubMed" id="12835319"/>
<dbReference type="DOI" id="10.1074/jbc.m305606200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF CYS-144; CYS-157 AND CYS-221</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Immunol." volume="172" first="6994" last="7001">
<title>Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.</title>
<authorList>
<person name="Postma B."/>
<person name="Poppelier M.J.J.G."/>
<person name="van Galen J.C."/>
<person name="Prossnitz E.R."/>
<person name="van Strijp J.A.G."/>
<person name="de Haas C.J.C."/>
<person name="van Kessel K.P.M."/>
</authorList>
<dbReference type="PubMed" id="15153520"/>
<dbReference type="DOI" id="10.4049/jimmunol.172.11.6994"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHIPS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="2020" last="2027">
<title>Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.</title>
<authorList>
<person name="Postma B."/>
<person name="Kleibeuker W."/>
<person name="Poppelier M.J.J.G."/>
<person name="Boonstra M."/>
<person name="van Kessel K.P.M."/>
<person name="van Strijp J.A.G."/>
<person name="de Haas C.J.C."/>
</authorList>
<dbReference type="PubMed" id="15542591"/>
<dbReference type="DOI" id="10.1074/jbc.m412230200"/>
</citation>
<scope>INTERACTION WITH CHIPS</scope>
<scope>MUTAGENESIS OF ASP-10; GLY-12; TYR-14; ASP-15 AND ASP-18</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Acta Pharmacol. Sin." volume="32" first="1038" last="1044">
<title>Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.</title>
<authorList>
<person name="Liu Z.J."/>
<person name="Yang Y.J."/>
<person name="Jiang L."/>
<person name="Xu Y.C."/>
<person name="Wang A.X."/>
<person name="Du G.H."/>
<person name="Gao J.M."/>
</authorList>
<dbReference type="PubMed" id="21706042"/>
<dbReference type="DOI" id="10.1038/aps.2011.53"/>
</citation>
<scope>INTERACTION WITH CHIPS</scope>
<scope>MUTAGENESIS OF TYR-11 AND TYR-14</scope>
</reference>
<reference key="19" evidence="1">
<citation type="journal article" date="2018" name="Nature" volume="553" first="111" last="114">
<title>Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.</title>
<authorList>
<person name="Robertson N."/>
<person name="Rappas M."/>
<person name="Dore A.S."/>
<person name="Brown J."/>
<person name="Bottegoni G."/>
<person name="Koglin M."/>
<person name="Cansfield J."/>
<person name="Jazayeri A."/>
<person name="Cooke R.M."/>
<person name="Marshall F.H."/>
</authorList>
<dbReference type="PubMed" id="29300009"/>
<dbReference type="DOI" id="10.1038/nature25025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 31-333</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text evidence="5 9 12 15 16 18 20">Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a (PubMed:1847994, PubMed:8182049, PubMed:7622471, PubMed:9553099, PubMed:10636859, PubMed:15153520, PubMed:29300009). The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transmembrane region which activates downstream signaling events (PubMed:8182049, PubMed:7622471, PubMed:9553099). Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production (PubMed:10636859, PubMed:15153520).</text>
</comment>
<comment type="subunit">
<text evidence="7 8 9 11 14 23">Homodimer. May also form higher-order oligomers (PubMed:12835319). Interacts (when phosphorylated) with ARRB1 and ARRB2; the interaction is associated with internalization of C5aR (PubMed:12464600). Interacts (via N-terminal domain) with S.aureus chemotaxis inhibitory protein (CHIPS); the interaction blocks the receptor and may thus inhibit the immune response (PubMed:15153520, PubMed:15542591, PubMed:21706042).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 15">Cell membrane</location>
<topology evidence="15">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Cytoplasmic vesicle</location>
</subcellularLocation>
<text evidence="7">Phosphorylated C5aR colocalizes with ARRB1 and ARRB2 in cytoplasmic vesicles.</text>
</comment>
<comment type="PTM">
<text evidence="6 24">Sulfation plays a critical role in the association of C5aR with C5a, but no significant role in the ability of the receptor to transduce a signal and mobilize calcium in response to a small a small peptide agonist (PubMed:11342590). Sulfation at Tyr-14 is important for CHIPS binding (PubMed:21706042).</text>
</comment>
<comment type="PTM">
<text evidence="5 7">Phosphorylated on serine residues in response to C5a binding, resulting in internalization of the receptor and short-term desensitization to the ligand. The key residues involved in this process are Ser-334 and Ser-338.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the G-protein coupled receptor 1 family.</text>
</comment>
<dbReference type="EMBL" id="M62505">
<property type="protein sequence ID" value="AAA62831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57250">
<property type="protein sequence ID" value="CAA40530.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X58674">
<property type="protein sequence ID" value="CAB37830.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY221091">
<property type="protein sequence ID" value="AAO65969.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007358">
<property type="protein sequence ID" value="AAP36022.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC099491">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008982">
<property type="protein sequence ID" value="AAH08982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S56556">
<property type="protein sequence ID" value="AAD14919.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S56557">
<property type="protein sequence ID" value="AAD14919.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33063.1"/>
<dbReference type="PIR" id="A37963">
<property type="entry name" value="A37963"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001727.1">
<property type="nucleotide sequence ID" value="NM_001736.3"/>
</dbReference>
<dbReference type="PDB" id="5O9H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=31-333"/>
</dbReference>
<dbReference type="PDB" id="6C1Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=30-331"/>
</dbReference>
<dbReference type="PDB" id="6C1R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=30-331"/>
</dbReference>
<dbReference type="PDBsum" id="5O9H"/>
<dbReference type="PDBsum" id="6C1Q"/>
<dbReference type="PDBsum" id="6C1R"/>
<dbReference type="SMR" id="P21730"/>
<dbReference type="BioGRID" id="107189">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="IntAct" id="P21730">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000347197"/>
<dbReference type="BindingDB" id="P21730"/>
<dbReference type="ChEMBL" id="CHEMBL2373"/>
<dbReference type="GuidetoPHARMACOLOGY" id="32"/>
<dbReference type="TCDB" id="9.A.14.13.26">
<property type="family name" value="the g-protein-coupled receptor (gpcr) family"/>
</dbReference>
<dbReference type="GlyGen" id="P21730">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P21730"/>
<dbReference type="PhosphoSitePlus" id="P21730"/>
<dbReference type="BioMuta" id="C5AR1"/>
<dbReference type="DMDM" id="311033355"/>
<dbReference type="jPOST" id="P21730"/>
<dbReference type="MassIVE" id="P21730"/>
<dbReference type="PaxDb" id="P21730"/>
<dbReference type="PeptideAtlas" id="P21730"/>
<dbReference type="PRIDE" id="P21730"/>
<dbReference type="ProteomicsDB" id="53893"/>
<dbReference type="ABCD" id="P21730">
<property type="antibodies" value="5 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="2966">
<property type="antibodies" value="960 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="728"/>
<dbReference type="Ensembl" id="ENST00000355085">
<property type="protein sequence ID" value="ENSP00000347197"/>
<property type="gene ID" value="ENSG00000197405"/>
</dbReference>
<dbReference type="GeneID" id="728"/>
<dbReference type="KEGG" id="hsa:728"/>
<dbReference type="UCSC" id="uc002pgj.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="728"/>
<dbReference type="DisGeNET" id="728"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197405.7"/>
<dbReference type="GeneCards" id="C5AR1"/>
<dbReference type="HGNC" id="HGNC:1338">
<property type="gene designation" value="C5AR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000197405">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MIM" id="113995">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21730"/>
<dbReference type="OpenTargets" id="ENSG00000197405"/>
<dbReference type="PharmGKB" id="PA25920"/>
<dbReference type="eggNOG" id="ENOG502R35Z">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00980000198522"/>
<dbReference type="HOGENOM" id="CLU_009579_8_0_1"/>
<dbReference type="InParanoid" id="P21730"/>
<dbReference type="KO" id="K04010"/>
<dbReference type="OMA" id="ACTLVKG"/>
<dbReference type="OrthoDB" id="978188at2759"/>
<dbReference type="PhylomeDB" id="P21730"/>
<dbReference type="TreeFam" id="TF330976"/>
<dbReference type="PathwayCommons" id="P21730"/>
<dbReference type="Reactome" id="R-HSA-375276">
<property type="pathway name" value="Peptide ligand-binding receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418594">
<property type="pathway name" value="G alpha (i) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977606">
<property type="pathway name" value="Regulation of Complement cascade"/>
</dbReference>
<dbReference type="SignaLink" id="P21730"/>
<dbReference type="SIGNOR" id="P21730"/>
<dbReference type="BioGRID-ORCS" id="728">
<property type="hits" value="3 hits in 866 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="C5AR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="C5a_receptor"/>
<dbReference type="GenomeRNAi" id="728"/>
<dbReference type="Pharos" id="P21730">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P21730"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P21730">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197405">
<property type="expression patterns" value="Expressed in blood and 188 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P21730">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P21730">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0045177">
<property type="term" value="C:apical part of cell"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030667">
<property type="term" value="C:secretory granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001856">
<property type="term" value="F:complement component C5a binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004878">
<property type="term" value="F:complement component C5a receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004875">
<property type="term" value="F:complement receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004930">
<property type="term" value="F:G protein-coupled receptor activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007202">
<property type="term" value="P:activation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0097242">
<property type="term" value="P:amyloid-beta clearance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048143">
<property type="term" value="P:astrocyte activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021534">
<property type="term" value="P:cell proliferation in hindbrain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006935">
<property type="term" value="P:chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050890">
<property type="term" value="P:cognition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038178">
<property type="term" value="P:complement component C5a signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002430">
<property type="term" value="P:complement receptor mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001774">
<property type="term" value="P:microglial cell activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042789">
<property type="term" value="P:mRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030593">
<property type="term" value="P:neutrophil chemotaxis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007200">
<property type="term" value="P:phospholipase C-activating G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010759">
<property type="term" value="P:positive regulation of macrophage chemotaxis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090023">
<property type="term" value="P:positive regulation of neutrophil chemotaxis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099172">
<property type="term" value="P:presynapse organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030449">
<property type="term" value="P:regulation of complement activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1902947">
<property type="term" value="P:regulation of tau-protein kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032494">
<property type="term" value="P:response to peptidoglycan"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007606">
<property type="term" value="P:sensory perception of chemical stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR001274">
<property type="entry name" value="Anaphtx_C5AR1/C5AR2"/>
</dbReference>
<dbReference type="InterPro" id="IPR002234">
<property type="entry name" value="Anphylx_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000826">
<property type="entry name" value="Formyl_rcpt-rel"/>
</dbReference>
<dbReference type="InterPro" id="IPR000276">
<property type="entry name" value="GPCR_Rhodpsn"/>
</dbReference>
<dbReference type="InterPro" id="IPR017452">
<property type="entry name" value="GPCR_Rhodpsn_7TM"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24225">
<property type="entry name" value="PTHR24225"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00001">
<property type="entry name" value="7tm_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01104">
<property type="entry name" value="ANPHYLATOXNR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00426">
<property type="entry name" value="C5ANPHYLTXNR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00237">
<property type="entry name" value="GPCRRHODOPSN"/>
</dbReference>
<dbReference type="PROSITE" id="PS00237">
<property type="entry name" value="G_PROTEIN_RECEP_F1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50262">
<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0765">Sulfation</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="C5a anaphylatoxin chemotactic receptor 1" id="PRO_0000069209">
<location>
<begin position="1"/>
<end position="350"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="15">
<location>
<begin position="1"/>
<end position="37"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="15">
<location>
<begin position="38"/>
<end position="64"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="15">
<location>
<begin position="65"/>
<end position="69"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="15">
<location>
<begin position="70"/>
<end position="93"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="15">
<location>
<begin position="94"/>
<end position="110"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="15">
<location>
<begin position="111"/>
<end position="132"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="15">
<location>
<begin position="133"/>
<end position="153"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="15">
<location>
<begin position="154"/>
<end position="174"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="15">
<location>
<begin position="175"/>
<end position="200"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="15">
<location>
<begin position="201"/>
<end position="226"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="15">
<location>
<begin position="227"/>
<end position="242"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="15">
<location>
<begin position="243"/>
<end position="265"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="15">
<location>
<begin position="266"/>
<end position="282"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="15">
<location>
<begin position="283"/>
<end position="303"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="15">
<location>
<begin position="304"/>
<end position="350"/>
</location>
</feature>
<feature type="region of interest" description="Required for CHIPS binding" evidence="11">
<location>
<begin position="10"/>
<end position="18"/>
</location>
</feature>
<feature type="region of interest" description="Involved in C5a binding" evidence="20">
<location>
<begin position="21"/>
<end position="30"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="6">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="6">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="314"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 17">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 17">
<location>
<position position="327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 17">
<location>
<position position="332"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 17">
<location>
<position position="334"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 17">
<location>
<position position="338"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="5"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 4 15">
<location>
<begin position="109"/>
<end position="188"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4467185." id="VAR_049377" evidence="10 12 13 19 21 22">
<original>D</original>
<variation>N</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11880097." id="VAR_049378" evidence="10 12 13 21 22">
<original>K</original>
<variation>N</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding (45,000-fold)." evidence="18">
<location>
<begin position="2"/>
<end position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs C5a binding. Strongly impairs C5a binding; when associated with A-27." evidence="18">
<location>
<begin position="2"/>
<end position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with A-15; A-16; A-18 and A-21 (PubMed:8182049). Moderately impairs CHIPS binding (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-15 (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-18 (PubMed:15542591)." evidence="11 18">
<original>D</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Weakly impairs CHIPS binding. Loss of CHIPS binding; when associated with F-14." evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately impairs CHIPS binding." evidence="11">
<original>G</original>
<variation>A</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="mutagenesis site" description="Weakly impairs CHIPS binding (PubMed:15542591). Strongly impairs CHIPS binding (PubMed:21706042). Loss of CHIPS binding; when associated with F-11 (PubMed:21706042)." evidence="11 14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with A-10; A-16; A-18 and A-21 (PubMed:8182049). Moderately impairs CHIPS binding (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-10 (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-18 (PubMed:15542591)." evidence="11 18">
<original>D</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with A-10; A-15; A-18 and A-21." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with A-10; A-15; A-16 and A-21 (PubMed:8182049). Impairs CHIPS binding (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-10 (PubMed:15542591). Strongly impairs CHIPS binding; when associated with A-15 (PubMed:15542591)." evidence="11 18">
<original>D</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with A-10; A-15; A-16 and A-18." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs C5a binding; when associated with 2-D--L-22 Del." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="mutagenesis site" description="Fails to homodimerize." evidence="8">
<original>C</original>
<variation>S</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on homodimer formation." evidence="8">
<original>C</original>
<variation>S</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs C5a binding (10-fold reduction) and C5a-induced 5-HT secretion." evidence="16">
<original>E</original>
<variation>Q</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on homodimer formation." evidence="8">
<original>C</original>
<variation>S</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="35"/>
<end position="65"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="70"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="89"/>
<end position="97"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="98"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="106"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="115"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="141"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="150"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="175"/>
<end position="180"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="181"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="185"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="196"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="212"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="238"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="273"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="282"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="292"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="315"/>
<end position="323"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5O9H"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6C1R"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00521"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10636859"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11342590"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12464600"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12835319"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15153520"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15542591"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1847994"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2007135"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21706042"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29300009"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7622471"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7642584"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8182049"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8383526"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9553099"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12835319"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21706042"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7642584"/>
</source>
</evidence>
<sequence length="350" mass="39336" checksum="9334BB39A2C96D3D" modified="2010-11-02" version="2">MDSFNYTTPDYGHYDDKDTLDLNTPVDKTSNTLRVPDILALVIFAVVFLVGVLGNALVVWVTAFEAKRTINAIWFLNLAVADFLSCLALPILFTSIVQHHHWPFGGAACSILPSLILLNMYASILLLATISADRFLLVFKPIWCQNFRGAGLAWIACAVAWGLALLLTIPSFLYRVVREEYFPPKVLCGVDYSHDKRRERAVAIVRLVLGFLWPLLTLTICYTFILLRTWSRRATRSTKTLKVVVAVVASFFIFWLPYQVTGIMMSFLEPSSPTFLLLKKLDSLCVSFAYINCCINPIIYVVAGQGFQGRLRKSLPSLLRNVLTEESVVRESKSFTRSTVDTMAQKTQAV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

